OXYDEX

A tetracycline analog isolated from the actinomycete streptomyces rimosus and used in a wide variety of clinical conditions.

Oxytetracycline is indicated for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae.

Oxytetracycline is known as a broad-spectrum antibiotic due to its activity against such a wide range of infections.

It was the second of the tetracyclines to be discovered.

Oxytetracycline, like other tetracyclines, is used to treat many infections common and rare.

Its better absorption profile makes it preferable to tetracycline for moderately severe acne, but alternatives sould be sought if no improvement occurs by 3 months.

Small ribosomal subunit protein uS9 (Escherichia coli (strain K12)) Inhibitor Small ribosomal subunit protein uS4 (Escherichia coli (strain K12)) Inhibitor.

Readily absorbed following oral administration.

Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.

View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.

Adverse effects may include stomach or bowel upsets and rarely allergic reactions.

Very rarely severe headache and vision problems may be signs of dangerous intracranial hypertenion.